背景与目的已有研究证实KLF4基因(Krüppel-like factor4)和富含半胱氨酸的酸性分泌蛋白(se-creted protein acidic and rich in cysteine,SPARC)与肿瘤的发生发展密切相关。本研究旨在检测KLF4和SPARC蛋白在非小细胞肺癌(non-small...背景与目的已有研究证实KLF4基因(Krüppel-like factor4)和富含半胱氨酸的酸性分泌蛋白(se-creted protein acidic and rich in cysteine,SPARC)与肿瘤的发生发展密切相关。本研究旨在检测KLF4和SPARC蛋白在非小细胞肺癌(non-small cell lung cancer,NSCLC)中的表达,并结合临床病理特征来探讨KLF4和SPARC的临床意义及相关性。方法应用免疫组织化学方法检测89例NSCLC组织及正常肺组织中KLF4和SPARC的表达。结果 KLF4在癌旁正常肺组织阳性表达率为88.8%,NSCLC组织为42.7%(P<0.05);有、无淋巴结转移者的KLF4阳性表达率分别为31.3%和56.1%(P<0.05);KLF4的表达与肿瘤临床分期有关(P<0.05),随着临床分期等级的增加,KLF4表达呈现递减趋势。SPARC在NSCLC组织的阳性表达率为70.8%,癌旁正常肺组织为7.9%(P<0.05);低、高分化癌的SPARC阳性表达率无统计学差异(P>0.05);有、无淋巴结转移者的SPARC阳性表达率分别为81.3%和58.5%(P<0.05);其表达与肿瘤的临床分期相关(P<0.05)。KLF4和SPARC的表达均与患者的性别、年龄和肿瘤大小无关(P>0.05)。SPARC和KLF4在NSCLC中的表达呈负相关(r=-0.245,P<0.05)。结论 KLF4低表达及SPARC的过表达与NSCLC的发生及其生物学行为密切相关,可能作为NSCLC诊断及分期预后的指标。展开更多
Vascular smooth muscle cell (VSMC) differentiation and proliferation are two important physiological proc- esses during vascular development. The phenotypic alteration from differentiated to proliferative VSMC contr...Vascular smooth muscle cell (VSMC) differentiation and proliferation are two important physiological proc- esses during vascular development. The phenotypic alteration from differentiated to proliferative VSMC contrib- utes to the development of several major cardiovascular diseases including atherosclerosis, hypertension, resteno- sis after angioplasty or bypass, diabetic vascular complications, and transplantation arteriopathy. Since the VSMC phenotype in these pathological conditions resembles that of developing VSMC during embryonic development, understanding of the molecular mechanisms that control VSMC differentiation will provide fundamental insights into the pathological processes of these cardiovascular diseases. Although VSMC differentiation is usually ac- companied by an irreversible cell cycle exit, VSMC proliferation and differentiation occur concurrently during embryonic development. The molecular mechanisms simultaneously regulating these two processes, however, remain largely unknown. Our recent study demonstrates that cell division cycle 7, a key regulator of cell cycle, promotes both VSMC differentiation and proliferation through different mechanisms during the initial phase of VSMC differentiation. Conversely, Kriappel-like factor 4 appears to be a repressor for both VSMC differentia- tion and proliferation. This review attempts to highlight the novel role of cell division cycle 7 in TGF-β-induced VSMC differentiation and proliferation. The role of K141ppel-like factor 4 in suppressing these two processes will also be discussed.展开更多
文摘背景与目的已有研究证实KLF4基因(Krüppel-like factor4)和富含半胱氨酸的酸性分泌蛋白(se-creted protein acidic and rich in cysteine,SPARC)与肿瘤的发生发展密切相关。本研究旨在检测KLF4和SPARC蛋白在非小细胞肺癌(non-small cell lung cancer,NSCLC)中的表达,并结合临床病理特征来探讨KLF4和SPARC的临床意义及相关性。方法应用免疫组织化学方法检测89例NSCLC组织及正常肺组织中KLF4和SPARC的表达。结果 KLF4在癌旁正常肺组织阳性表达率为88.8%,NSCLC组织为42.7%(P<0.05);有、无淋巴结转移者的KLF4阳性表达率分别为31.3%和56.1%(P<0.05);KLF4的表达与肿瘤临床分期有关(P<0.05),随着临床分期等级的增加,KLF4表达呈现递减趋势。SPARC在NSCLC组织的阳性表达率为70.8%,癌旁正常肺组织为7.9%(P<0.05);低、高分化癌的SPARC阳性表达率无统计学差异(P>0.05);有、无淋巴结转移者的SPARC阳性表达率分别为81.3%和58.5%(P<0.05);其表达与肿瘤的临床分期相关(P<0.05)。KLF4和SPARC的表达均与患者的性别、年龄和肿瘤大小无关(P>0.05)。SPARC和KLF4在NSCLC中的表达呈负相关(r=-0.245,P<0.05)。结论 KLF4低表达及SPARC的过表达与NSCLC的发生及其生物学行为密切相关,可能作为NSCLC诊断及分期预后的指标。
基金supported by grants from National Institutes of Health (HL093429 and HL107526 to S.-Y.C.)
文摘Vascular smooth muscle cell (VSMC) differentiation and proliferation are two important physiological proc- esses during vascular development. The phenotypic alteration from differentiated to proliferative VSMC contrib- utes to the development of several major cardiovascular diseases including atherosclerosis, hypertension, resteno- sis after angioplasty or bypass, diabetic vascular complications, and transplantation arteriopathy. Since the VSMC phenotype in these pathological conditions resembles that of developing VSMC during embryonic development, understanding of the molecular mechanisms that control VSMC differentiation will provide fundamental insights into the pathological processes of these cardiovascular diseases. Although VSMC differentiation is usually ac- companied by an irreversible cell cycle exit, VSMC proliferation and differentiation occur concurrently during embryonic development. The molecular mechanisms simultaneously regulating these two processes, however, remain largely unknown. Our recent study demonstrates that cell division cycle 7, a key regulator of cell cycle, promotes both VSMC differentiation and proliferation through different mechanisms during the initial phase of VSMC differentiation. Conversely, Kriappel-like factor 4 appears to be a repressor for both VSMC differentia- tion and proliferation. This review attempts to highlight the novel role of cell division cycle 7 in TGF-β-induced VSMC differentiation and proliferation. The role of K141ppel-like factor 4 in suppressing these two processes will also be discussed.